The FDA also cited data from Pfizer, which had said earlier this month it was evaluating a potential three-dose series for children as young as 6 months old.
The FDA said it based the decision on promising data from Israel, which rolled out booster shots for residents as young as 12 there in August, for those who had received their second dose at least five months earlier.
https://www.cbsnews.com/news/covid-vacci...years-old/
The FDA said it based the decision on promising data from Israel, which rolled out booster shots for residents as young as 12 there in August, for those who had received their second dose at least five months earlier.
https://www.cbsnews.com/news/covid-vacci...years-old/